Literature DB >> 7655622

Gas chromatographic-mass spectrometric identification and quantitation of ethylene glycol in serum after derivatization with perfluorooctanoyl chloride: a novel derivative.

A Dasgupta1, W Blackwell, J Griego, S Malik.   

Abstract

Ethylene glycol poisoning is a common clinical problem and identification as well as quantitation of ethylene glycol in serum is important for medical and legal purposes. Most investigators described determination of ethylene glycol by gas chromatography without derivatization or derivatives forming a molecular ion < 200. We describe a novel derivatization technique of ethylene glycol using perfluorooctanoyl chloride, after extraction from serum using acetone. This derivative has a molecular mass of 854 and produces a base peak at m/z 441 and other diagnostic strong peaks for unambiguous identification. Moreover, this derivative is less volatile and is free from interferences from endogenous serum components. Quantitation can be achieved by using 1,4-butanediol as an internal standard. The assay showed within-run and between-run precision of 7.2% and 8.0%, respectively, and linearity over the serum ethylene glycol concentration range 70-2240 micrograms/ml with a detection limit of 5 micrograms/ml.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7655622     DOI: 10.1016/0378-4347(94)00566-n

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Appl        ISSN: 1572-6495


  2 in total

1.  Use of a Rapid Ethylene Glycol Assay: a 4-Year Retrospective Study at an Academic Medical Center.

Authors:  Sydney L Rooney; Alexandra Ehlers; Cory Morris; Denny Drees; Scott R Davis; Jeff Kulhavy; Matthew D Krasowski
Journal:  J Med Toxicol       Date:  2016-06

2.  Ethylene glycol: Evidence of glucuronidation in vivo shown by analysis of clinical toxicology samples.

Authors:  Daniel Sejer Pedersen; Patrick Bélanger; Mikael Frykman; Kirsten Andreasen; Danielle Goudreault; Henrik Pedersen; Peter Hindersson; Torben Breindahl
Journal:  Drug Test Anal       Date:  2019-04-17       Impact factor: 3.345

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.